Altogether, these results demonstrate that in vivo treatment of MYCN-amplified neuroblastoma with antagomir-17-5p abolishes tumor growth by upmodulation of p21 and BIM and increased apoptosis. The gene discussed is BCL2L11; the disease is neoplasm.